Latest1 information on COVID-19
Support teaching, research, and patient care.
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Richard Fu
1 650-497-8815
All fields are required. *
We were not able to send your contact info at this time.